IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -50.0% | 618 | -11.2% | 0.00% | -100.0% |
| Q3 2016 | $16,000 | -23.8% | 696 | -5.9% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | -12.5% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $24,000 | -20.0% | 740 | +6.3% | 0.00% | 0.0% |
| Q4 2015 | $30,000 | +20.0% | 696 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $25,000 | -50.0% | 696 | -36.4% | 0.00% | -50.0% |
| Q2 2015 | $50,000 | -7.4% | 1,094 | -5.8% | 0.00% | 0.0% |
| Q1 2015 | $54,000 | +38.5% | 1,161 | -6.0% | 0.00% | 0.0% |
| Q4 2014 | $39,000 | +14.7% | 1,235 | -13.9% | 0.00% | 0.0% |
| Q3 2014 | $34,000 | -20.9% | 1,435 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $43,000 | -48.8% | 1,435 | -55.2% | 0.01% | 0.0% |
| Q1 2014 | $84,000 | 0.0% | 3,202 | -3.9% | 0.01% | -53.8% |
| Q4 2013 | $84,000 | +42.4% | 3,331 | +12.1% | 0.01% | +8.3% |
| Q2 2013 | $59,000 | – | 2,972 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |